Abbott confirms capacity to support expanded use of heartmate 3™ heart pump

Abbott park, ill., june 3, 2021 /prnewswire/ -- abbott (nyse: abt) today announced the company has capacity and supply to effectively support the growing demand for mechanical circulatory support (mcs) devices for the effective treatment of advanced heart failure following medtronic's decision to stop the global distribution and sale of the medtronic heartware™ ventricular assist device (hvad).
ABT Ratings Summary
ABT Quant Ranking